← All trials
NCT05592678
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2023
- Primary completion
- Feb 28, 2027
- Completion date
- Nov 30, 2027
- First posted
- Oct 25, 2022
- Last posted
- Oct 25, 2022
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas, San AntonioLead sponsor
- National Institute on Aging (NIA)Collaborator
- University of Texas, GalvestonOverall official - principal investigator
- University of Texas, San AntonioReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.